RFI: modernization of reactive skin decontamination lotion (RSDL), a U. S. Food and drug administration (FDA) approved product
Closed Pre-Solicitation Posted
- Solicitation number
- W911SR-24-R-RSDL
- Agency
-
ACC Aberdeen Proving Ground
Army Contracting Command, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- Frederick, Maryland, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of the Army Materiel Command Army Contracting Command Aberdeen Proving Ground has issued a Request for Information (RFI) for the modernization of the Reactive Skin Decontamination Lotion (RSDL), a U.S. Food and Drug Administration (FDA) approved product. The RFI is being issued by the Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical) and the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND). Key requirements include equal or higher efficacy than the current RSDL, the ability to be stored without controlled temperature and humidity, a shelf life greater than five years, the ability to be reshelved after distribution if not used, and availability in both a personnel spot decontamination form and an approved form for bulk use in a mass casualty scenario. Responses to the RFI are due by COB on May 31, 2024.
This RFI is not a set-aside and does not indicate the existence of a solicitation document or a guarantee that one will be issued. There are no identified incumbents or potential contractors. The RFI is for planning purposes only, and the government will not pay for the information requested. No award value or budget range is provided.
Notice text
This is a Request for Information (RFI) for planning purposes only. It is not to be construed as a commitment by the government nor will the government pay for the information requested. No solicitation document exists or is guaranteed to be issued as a result of this RFI.
The Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical) and the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) is seeking information on the available capabilities and willingness of private entities (academic, non-profit, and commercial) to collaborate with the government for improving, modernizing or replacing RSDL®. Please see the attached RFI for a full list of requested performance objectives and information requested.
Files
| File | Type | Posted |
|---|---|---|
| Modernization of RSDL RFI_Final.pdf |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity